Trial Profile
A Phase II Clinical Trial of Ixabepilone (Ixempra, BMS-247550, NSC 710428), an Epothilone B Analog, in Cervical Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2019
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 13 Nov 2019 Status changed from completed to discontinued.
- 13 Nov 2019 Status changed from completed to discontinued.
- 01 Dec 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.